['chronic kidney disease', 'type 2 diabetes']
['rta 402', 'placebo']

        Inclusion Criteria:

          -  CKD patients with type 2 diabetes mellitus

          -  Patients whose estimated GFR levels are eligible for this study

          -  Patients being treated with stable dose of angiotensin converting enzyme (ACE)
             inhibitors and/or angiotensin II receptor blocker (ARB) etc.

        Exclusion Criteria:

          -  Patients with type 1 diabetes mellitus

          -  Patients with known non-diabetic renal disease

          -  Patients with a history of renal transplantation

          -  Patients with mean systolic blood pressure > 160 mmHg or diastolic blood pressure > 90
             mmHg

          -  Patients with Hemoglobin A1c > 10%

          -  Patients with cardiovascular disease specified in the study protocol etc.
      